Showing results (1141-1150 of 5,723) with videos related to
Sort By:
Pageof 573
Medical Oncology (Northwood, London, England)|July 10, 2012
Long-term outcome of continuous 5-fluorouracil/cisplatin-based chemotherapy followed by chemoradiation in patients with resected gastric cancerAmir Sonnenblick, Yakir Rottenberg, Luna Kadouri, et al.Medical Oncology (Northwood, London, England)|August 3, 2012
Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomasYi-Li Zhou, Chao Liu, Xuan-xuan Dai, et al.Medical Oncology (Northwood, London, England)|July 5, 2012
RARS with fibrosis and del(20q) transformed into ALLSandra S Rohr, Luís Arthur Flores Pelloso, Aline dos Santos Borgo, et al.Medical Oncology (Northwood, London, England)|March 20, 2010
β-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cellsXiangrong Liu, Lei Wang, Shangfeng Zhao, et al.Medical Oncology (Northwood, London, England)|March 20, 2010
Gemcitabine and cisplatin in patients with carcinoma of unknown primary siteMetin Isik, Mehmet M Seker, Hatice Odabas, et al.Medical Oncology (Northwood, London, England)|March 20, 2010
Clinical significance of the ratio between the alpha 2 plasmin inhibitor-plasmin complex and the thrombin-antithrombin complex in advanced non-small cell lung cancerKatsuhiro Masago, Shiro Fujita, Tadashi Mio, et al.Medical Oncology (Northwood, London, England)|March 23, 2010
Prolonged time to progression with fulvestrant for metastatic breast cancerCelso A L Mello, Ludmilla T D Chinen, Samantha Cabral Severino da Silva, et al.Medical Oncology (Northwood, London, England)|February 11, 2015
CD40 expression and its prognostic significance in human gastric carcinomaJing Guo, Jia-Jia Xiao, Xiaoli Zhang, et al.Medical Oncology (Northwood, London, England)|February 2, 2015
Continuous, low-dose capecitabine for patients with recurrent colorectal cancerAdriana Romiti, Concetta Elisa Onesti, Michela Roberto, et al.Medical Oncology (Northwood, London, England)|February 22, 2015
VGLL4 inhibits EMT in part through suppressing Wnt/β-catenin signaling pathway in gastric cancerHui Li, Ziwei Wang, Wei Zhang, et al.Pageof 573